STRATA Skin Sciences

72 articles about STRATA Skin Sciences

• STRATA Skin Sciences Announces Poster Accepted at ODAC Dermatology, Aesthetic & Surgical Conference

  1/13/2023

  STRATA Skin Sciences, Inc. today announced a poster titled “Advancement of Personalized Photopneumatic Therapy for Rapid, Visible Improvement In Patients Mild to Moderate Acne” was accepted at the ODAC Dermatology, Aesthetic & Surgical Conference held at the JW Marriott Grande Lakes.

• STRATA Skin Sciences to Participate at Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech/Diagnostic Conference

  12/2/2022

  STRATA Skin Sciences, Inc. announced the company will present at the Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech/Diagnostic Conference being held at the Fontainebleau Miami Beach, Miami, Florida on December 8, 2022.

• STRATA Skin Sciences Reports Strong Third Quarter 2022 Financial Results

  11/9/2022

  STRATA Skin Sciences, Inc. announced strong financial results for the third quarter ended September 30, 2022.

• STRATA Skin Sciences to Report Third Quarter 2022 Financial Results on November 9, 2022

  10/26/2022

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced that it plans to release its third quarter 2022 financial results on Wednesday, November 9, 2022.

• STRATA Skin Sciences to Participate at Upcoming October 2022 Investor Conferences

  10/6/2022

  STRATA Skin Sciences, Inc. announced the company will present at the Midcap Rodeo: Windy City Roundup 2022 and the LD Micro Main Event XV.

• STRATA Skin Sciences to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

  8/22/2022

  STRATA Skin Sciences, Inc. today announced the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually.

• STRATA Skin Sciences Reports Second Quarter 2022 Financial Results

  8/10/2022

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced financial results for the second quarter ended June 30, 2022.

• STRATA Skin Sciences Announces Upcoming KOL Call Hosted by Ladenburg Thalmann

  8/2/2022

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced that the Company’s XTRAC Excimer Laser will be highlighted in an upcoming Key Opinion Leader Call hosted by Ladenburg Thalmann.

• STRATA Skin Sciences to Report Second Quarter 2022 Financial Results on August 10, 2022

  7/27/2022

  STRATA Skin Sciences, Inc. announced that it plans to release its second quarter 2022 financial results on Wednesday, August 10, 2022.

• STRATA Skin Sciences to Participate in the Lytham Partners Summer 2022 Investor Conference

  6/7/2022

  STRATA Skin Sciences, Inc. announced that it will be participating in the Lytham Partners Summer 2022 Investor Conference taking place virtually on June 21-22, 2022.

• STRATA Skin Sciences Reports First Quarter 2022 Financial Results

  5/11/2022

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced financial results for the first quarter ended March 31, 2022.

• STRATA Skin Sciences to Report First Quarter 2022 Financial Results on May 11, 2022

  4/27/2022

  STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its first quarter 2022 financial results on Wednesday, May 11, 2022.

• STRATA Skin Sciences to Participate in the Lytham Partners Spring 2022 Investor Conference

  3/28/2022

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced that it will be participating in the Lytham Partners Spring 2022 Investor Conference taking place virtually on April 4-7, 2022.

• STRATA Skin Sciences Reports Record Fourth Quarter 2021 Revenue

  3/21/2022

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced financial results for the fourth quarter and full year ended December 31, 2021.

• STRATA Skin Sciences Names John Bagdasarian as Vice President of Professional Relations

  3/14/2022

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced that John Bagdasarian has joined the company as Vice President of Professional Relations.

• STRATA Skin Sciences to Report Fourth Quarter and Full Year 2021 Financial Results on March 21, 2022

  3/7/2022

  STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its fourth quarter and full year 2021 financial results on Monday, March 21, 2022.

• STRATA Skin Sciences to Participate in the Upcoming Oppenheimer 32nd Annual Healthcare Conference

  3/3/2022

  STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the Company will participate in the upcoming Oppenheimer 32nd Annual Healthcare Conference.

• STRATA Skin Sciences Appoints Patricia S. Walker, M.D., Ph.D. to its Board of Directors

  2/14/2022

  STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced that effective today, Patricia S. Walker M.D., PhD. has been appointed to its Board of Directors.

• STRATA Skin Sciences Announces Commercial Launch of XTRAC Momentum™ 1.0 and First Installation in the U.S.

  2/9/2022

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced its commercial launch, with the first installation in the U.S. market, of its next generation excimer laser system, XTRAC Momentum™ 1.0.

• STRATA Skin Sciences Expands into Israel with Leading Medical Device Distributor

  1/18/2022

  STRATA Skin Sciences, Inc. announced that it has entered into an agreement with JuvenIL, the dermatology and aesthetics portion of Trimaco, a leading distributor in Israel for medical devices and innovation, to supply STRATA’s XTRAC® excimer lasers in Israel.